Chemicals Diversified Chemicals

More

  • ChemChina to buy Sygenta for $43 billion

    CNBC's Julia Chatterley reports from Basel on Syngenta and the takeover deal by ChemChina, a Chinese state-owned company.

  • Ren Jianxin

    ChemChina is nearing a deal to take over Syngenta for around $42 billion, two people familiar with the matter told Reuters.

  • Axiall said on Friday that it had rejected Westlake's $1.4 billion takeover offer, saying it undervalued the company- an argument that Brigade Capital agreed with. Brigade Capital said in a letter to Axiall's board that it opposed the use of a "poison pill" with respect to Westlake's offer of $20 per share. Axiall shares were down 2.6 percent at $17.46 in afternoon...

  • Westlake, a Houston- based manufacturer and supplier of petrochemicals, polymers and building products, had argued that the combined company would be more diversified and have a stronger financial profile than Axiall on its own. Westlake revealed earlier on Friday that on Jan. 25 it had offered $11 per share in cash and 0.1967 of its stock for each Axiall share.

  • The production plant for high density polyethylene of Dow Chemical in Tessenderlo.

    Dow Chemical and DuPont are expected to announce a merger of equals by Thursday, sources told CNBC.

  • Andrew Liveris, CEO of Dow Chemical at 2015 WEF in Davos, Switzerland.

    Dow reported a better-than-expected quarterly profit, helped by higher margins in five of its six units.

  • Andrew Liveris, CEO of Dow Chemical at 2015 WEF in Davos, Switzerland.

    Stable, low oil prices are good because the drop in crude is supply-driven and will act as stimulus, Dow Chemical CEO Andrew Liveris tells CNBC.

  • DuPont reported a 52 percent jump in profit as operating margins rose in five of its seven businesses.

  • Oshkosh Corporation chief engineer for Unmanned Systems, demonstrates a remote steering device for the TerraMax autonomous vehicle on a test course outside of Pittsburgh, Pennsylvania.

    Investors seeking steady gains on innovation should look past tech buzz. When R&D productivity is measured, 'boring' stocks often lead.